Subject: S7-18-21: WebForm Comments from Andrew Romero
From: Andrew Romero
Affiliation: Clinical Trials Manager for large pharma company

Oct. 08, 2022



October 8, 2022

 the 15-minute reporting requirement is extremely justified in preventing massive oversights in SEC compliance such as Archegos and the continued GameStop shorting issue.

Also in pharma, many small cap biotechs are constantly affected by illegal shorting tactics as binary plays based on FDA approval,denial or comments on clinical trials. Having this requirement is key to making sure bad actors are kept in check and a track record is established for litigation